Effect of a Monofunctional Phenanthriplatin-DNA Adduct on RNA Polymerase II Transcriptional Fidelity and Translesion Synthesis
Transcription inhibition by platinum anticancer drugs is an important component of their mechanism of action. Phenanthriplatin, a cisplatin derivative containing phenanthridine in place of one of the chloride ligands, forms highly potent monofunctional adducts on DNA having a structure and spectrum...
Main Authors: | Kellinger, Matthew W., Park, Ga Young, Chong, Jenny, Lippard, Stephen J., Wang, Dong |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry |
Format: | Article |
Language: | en_US |
Published: |
American Chemical Society (ACS)
2014
|
Online Access: | http://hdl.handle.net/1721.1/88576 https://orcid.org/0000-0002-2693-4982 |
Similar Items
-
Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin
by: Riddell, Imogen Anne, et al.
Published: (2016) -
Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile
by: Park, Ga Young, et al.
Published: (2013) -
Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations
by: Hucke, Anna, et al.
Published: (2018) -
Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations
by: Anna Hucke, et al.
Published: (2018-05-01) -
X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct
by: Zhu, Guangyu, et al.
Published: (2013)